GlaxoSmithKline Shares News & Articles

Market report: Antofagasta jumps on Pakistan ruling, Sport Direct plunges after results delay

UK markets make modest gains in early trade on Monday reversing an extended losing streak with investors warming to positive news from mining group Antofagasta (ANTO), although news of delayed results by Mike Ashley’s Sports Direct (SPD) comes as another knock to the embattled UK retail space. Antofagasta announced today that the World Bank arbitration court has ordered the Pakistani ...

Market report: GardaWorld walks away from G4S, Domino's down on overseas disappointment

US President Donald Trump’s latest trade war tariff threat weighs on sentiment on Tuesday, with the FTSE 100 cheapening 17.4 points to 7, 363.2. However, weakness among banks and utilities is being softened by strength among pharma and mining stocks and investors are perhaps taking some comfort in the news that China’s vice-premier Liu He will travel to the US for another round of trade talks ...

Why Biogen’s decision to ditch global clinical trials in Alzheimer’s has spooked investors

US biotechnology giant Biogen’s shock decision to discontinue two Phase III clinical trials in Alzheimer’s disease has spooked investors, prompting declines in UK-listed pharmaceutical stocks. Shares in AstraZeneca (AZN) have fallen 2.1% to £63.88 while GlaxoSmithKline (GSK) was broadly unmoved at £15.62 after an initial dip of 0.7%. Over $18bn was wiped off Biogen’s market value on ...
Showing 1 to 20 of 302